Ledger.Open graph →
SEC Form D · Amendment · filed September 15, 2022

Armis Biopharma, Inc

Offering
$10.0M
Sold
$7.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FORT COLLINS, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Michael Litwack · Fort Collins, CODirectorTed Ziemann · Fort Collins, COExec · DirectorChristopher Ruud · Fort Collins, COExec · DirectorEd Neas, Ph.D · Fort Collins, CODirectorWilliam Nelson, Md. Ph.D · Fort Collins, CODirectorSteve Coder · Fort Collins, COExec · DirectorAlan Smith, Ph.D · Fort Collins, CODirectorAlan Ruud · Fort Collins, CADirectorKurt Gibson · Brandon, FLDirectorCS Starland Savannah 2023 Manager LLC · Morristown, NJDirectorArmaan Ali · SAN FRANCISCO, CADirectorMatthew G. Coleman · FORT WORTH, TXExec · DirectorLauren Chung · New York, NYDirectorChristopher Gibson · Brandon, FLExec · DirectorDeborah Ginsberg · NEW YORK, NYExec · DirectorSarah Baker · Portland, ORDirectorJulia O'Mara · New York, NYDirectorRick Heitzmann · New York, NYExec · DirectorBrian Mcmahon · New York, NYExec · DirectorQuinton C. Hennigh · Denver, COExec · DirectorOtavio C. Costa · Denver, CODirectorJeffery Sarrett · NEW YORK, NYDirectorAlan Ruud · Fort Collins, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗